Humana Inc.: updates and filings

HUMNYSEHealthcare · Hospital & Medical Service Plans

Price

$450.00

November 13, 2026Market cap $54.3B

DCF calculator

What Ploutos Investor adds for Humana

Part of Ploutos Investor, €9.99 a month

See the plans

The full history: 17 fiscal years, from 2009
The estimated fair value, with its range and its certainty
The full analysis, 18 a month
More questions to the chat on its filings
Excel with every year
An email when it reports, changes its dividend or an officer buys

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 75 daysAround Jan 29, 2027 · for Q4 2026

last Nov 6, 2026next Jan 29, 2027

An estimate from when it has reported before, which has been regular. The company announces the date itself.

November 2026

July 2026

May 2026

19TueDealMaterial agreement entered, new material financial obligationDocument

April 2026

March 2026

9MonDealMaterial agreement entered, new material financial obligation, other material eventsDocument

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Feb 19, 2026 latest annualNov 6, 2026 latest quarterly

Nov 9, 2026Other material events
Form8-K
Nov 6, 2026Quarterly reportfor the period to Sep 30, 2026
Form10-Q
Nov 6, 2026Results of operations, Regulation FD disclosure
Form8-K
Oct 13, 2026Regulation FD disclosure
Form8-K
Oct 9, 2026Regulation FD disclosure
Form8-K
Sep 1, 2026Regulation FD disclosure
Form8-K
Jul 29, 2026Quarterly reportfor the period to Jun 30, 2026
Form10-Q
Jul 29, 2026Officer or director change
Form8-K
Jul 29, 2026Results of operations, Regulation FD disclosure
Form8-K
Jun 24, 2026Employee stock plan reportfor the period to Dec 31, 2025
Form11-K
Jun 24, 2026Employee stock plan reportfor the period to Dec 31, 2025
Form11-K
Jun 1, 2026Regulation FD disclosure
Form8-K
May 19, 2026Material agreement entered, new material financial obligation
Form8-K
May 14, 2026Over-5% holder statement (passive) (amendment)
FormSCHEDULE 13G/A
Apr 30, 2026Over-5% holder statement (passive)
FormSCHEDULE 13G
Apr 29, 2026Quarterly reportfor the period to Mar 31, 2026
Form10-Q
Apr 29, 2026Results of operations, Regulation FD disclosure
Form8-K
Apr 20, 2026Shareholder vote
Form8-K
Apr 16, 2026Shares registered for employees
FormS-8
Apr 10, 2026Officer or director change
Form8-K
Mar 27, 2026Over-5% holder statement (passive) (amendment)
FormSCHEDULE 13G/A
Mar 9, 2026Material agreement entered, new material financial obligation, other material events
Form8-K
Mar 6, 2026Filing
FormDEFR14A
Mar 6, 2026Annual report to shareholdersfor the period to Dec 31, 2025
FormARS
Mar 6, 2026Additional annual meeting material
FormDEFA14A

Filed	Form	What it is	Filing
Nov 9, 2026	8-K	Other material events	Document
Nov 6, 2026	10-Q	Quarterly reportfor the period to Sep 30, 2026	Document
Nov 6, 2026	8-K	Results of operations, Regulation FD disclosure	Document
Oct 13, 2026	8-K	Regulation FD disclosure	Document
Oct 9, 2026	8-K	Regulation FD disclosure	Document
Sep 1, 2026	8-K	Regulation FD disclosure	Document
Jul 29, 2026	10-Q	Quarterly reportfor the period to Jun 30, 2026	Document
Jul 29, 2026	8-K	Officer or director change	Document
Jul 29, 2026	8-K	Results of operations, Regulation FD disclosure	Document
Jun 24, 2026	11-K	Employee stock plan reportfor the period to Dec 31, 2025	Document
Jun 24, 2026	11-K	Employee stock plan reportfor the period to Dec 31, 2025	Document
Jun 1, 2026	8-K	Regulation FD disclosure	Document
May 19, 2026	8-K	Material agreement entered, new material financial obligation	Document
May 14, 2026	SCHEDULE 13G/A	Over-5% holder statement (passive) (amendment)	Document
Apr 30, 2026	SCHEDULE 13G	Over-5% holder statement (passive)	Document
Apr 29, 2026	10-Q	Quarterly reportfor the period to Mar 31, 2026	Document
Apr 29, 2026	8-K	Results of operations, Regulation FD disclosure	Document
Apr 20, 2026	8-K	Shareholder vote	Document
Apr 16, 2026	S-8	Shares registered for employees	Document
Apr 10, 2026	8-K	Officer or director change	Document
Mar 27, 2026	SCHEDULE 13G/A	Over-5% holder statement (passive) (amendment)	Document
Mar 9, 2026	8-K	Material agreement entered, new material financial obligation, other material events	Document
Mar 6, 2026	DEFR14A	Filing	Document
Mar 6, 2026	ARS	Annual report to shareholdersfor the period to Dec 31, 2025	Document
Mar 6, 2026	DEFA14A	Additional annual meeting material	Document

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC since Feb 1, 1994: every report, 8-K, meeting and letter. Of its other filings (1,136 in all), the newest. Of its note and share prospectuses (424B, FWP), the newest 40 of 54.

And 2,324 filings on insiders' shares1,910 Form 4, 311 Form 144 and 93 Form 3 since Aug 12, 1996. Their trades are on the Ownership tab.

The full analysis

What do Humana's filings show?

The filings are where every one of Humana's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

A fair value range built from the filings
Earnings quality, debt and red flags
Insider and institutional moves
The case for and the case against

All filings on EDGAR

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.